Under Armour stock is on steroids but investors want more

April 21, 2015 1:47 PM

60 0

Under Armour stock is on steroids but investors want more

Remember last week when 21-year-old golfer Jordan Spieth won the Masters Tournament in Under Armour attire?

Under Armour execs are still talking about it. Spieth's victory was the equivalent of a corporate dunk on rival Nike (NKE). There's just one problem for Under Armour: investors have come to expect Masters-winning moments all the time from the company.

Also read: Germany's ThyssenKrupp Hit by Sustained Hacking Attack

Read more

To category page

Loading...